sulfinpyrazone has been researched along with Pulmonary Embolism in 10 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Altering the platelet behavior with sulfinpyrazone or heparin--probably by inhibiting the platelet release reaction--reduces the emboli-induced pulmonary hypertension to the same extent as platelet depletion." | 3.65 | Platelet-mediated pulmonary hypertension: reduction by platelet inhibition. ( Grover, RF; Mlczoch, J; Reeves, JT, 1977) |
| " It is concluded that when initiating and withdrawing treatment with SP in a patient receiving AC, the prothrombin time should be checked daily for a few days to adapt (reduce) the dosage of AC to the change in prothrombin time induced by SP." | 2.65 | [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol]. ( Fontanilles, F; Holt, NF; Michot, F, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verstraete, M | 2 |
| Michot, F | 1 |
| Holt, NF | 1 |
| Fontanilles, F | 1 |
| Loo, J | 1 |
| Gastpar, H | 1 |
| Mlczoch, J | 2 |
| Tucker, A | 1 |
| Weir, EK | 1 |
| Reeves, JT | 2 |
| Grover, RF | 2 |
| Rüegg, M | 1 |
| Genton, E | 2 |
| Gent, M | 1 |
| Hirsh, J | 1 |
| Harker, LA | 1 |
1 review available for sulfinpyrazone and Pulmonary Embolism
| Article | Year |
|---|---|
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprof | 1980 |
4 trials available for sulfinpyrazone and Pulmonary Embolism
| Article | Year |
|---|---|
[The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
Topics: Acenocoumarol; Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Clinical Trials as Topic | 1981 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrin | 1975 |
5 other studies available for sulfinpyrazone and Pulmonary Embolism
| Article | Year |
|---|---|
[Inhibition of cancer cell stickiness, a model for the testing of in vivo thrombocyte aggregation inhibitors. IV. Effect of sulfinpyrazone].
Topics: Animals; Blood Platelets; Carcinoma 256, Walker; Cell Aggregation; Cell Count; Neoplasm Transplantat | 1978 |
Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition.
Topics: Animals; Blood Platelets; Dogs; Female; Heparin; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary E | 1978 |
Platelet-mediated pulmonary hypertension: reduction by platelet inhibition.
Topics: Animals; Blood Platelets; Dogs; Heparin; Hypertension, Pulmonary; Pulmonary Circulation; Pulmonary E | 1977 |
Antithrombotic effects of sulfinpyrazone in animals: influence on fibrinolysis and sodium arachidonate-induced pulmonary embolism.
Topics: Animals; Arachidonic Acids; Blood Coagulation; Fibrinolysis; Humans; Male; Mice; Pulmonary Embolism; | 1976 |
Recognizing and reacting to recurrent pulmonary embolism.
Topics: Administration, Oral; Anticoagulants; Blood Platelet Disorders; Fibrinolytic Agents; Heparin; Humans | 1973 |